Max Healthcare Institute Ltd

Max Healthcare Institute Ltd

₹ 803 -0.93%
25 Apr 4:03 p.m.
About

Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]

Key Points

Leadership[1]
Max Healthcare is India’s second largest hospital chain in terms of revenue, EBITDA and market capitalisation.

  • Market Cap 78,088 Cr.
  • Current Price 803
  • High / Low 910 / 438
  • Stock P/E 73.9
  • Book Value 80.7
  • Dividend Yield 0.12 %
  • ROCE 15.0 %
  • ROE 16.1 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 115% CAGR over last 5 years
  • Debtor days have improved from 38.6 to 26.9 days.

Cons

  • Stock is trading at 9.96 times its book value
  • Company has a low return on equity of 11.0% over last 3 years.
  • Promoter holding has decreased over last 3 years: -46.7%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
796 802 1,000 1,018 976 937 1,067 1,137 1,142 1,215 1,285 1,363 1,335
635 634 756 779 728 729 802 818 828 874 948 976 949
Operating Profit 160 168 244 239 247 209 265 319 314 340 337 387 386
OPM % 20% 21% 24% 23% 25% 22% 25% 28% 28% 28% 26% 28% 29%
40 29 26 23 46 26 31 26 45 40 41 45 46
Interest 46 45 27 27 25 22 22 22 20 20 19 9 11
Depreciation 48 48 54 54 55 58 57 58 57 60 56 58 61
Profit before tax 105 104 190 182 213 154 216 265 281 301 303 366 360
Tax % 14% 33% 23% 20% 11% 20% 20% -72% 21% 17% 21% 24% 20%
90 70 147 145 190 124 173 457 222 251 240 277 289
EPS in Rs 1.00 0.72 1.52 1.50 1.96 1.28 1.78 4.72 2.29 2.58 2.47 2.85 2.98
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
1,608 1,729 1,691 1,059 2,508 3,937 4,563 5,198
1,467 1,616 1,535 965 2,101 2,986 3,322 3,747
Operating Profit 141 113 156 94 407 951 1,241 1,451
OPM % 9% 7% 9% 9% 16% 24% 27% 28%
59 65 56 48 -122 110 139 173
Interest 100 99 101 83 179 101 84 59
Depreciation 96 94 103 46 174 221 232 235
Profit before tax 5 -15 8 13 -69 739 1,064 1,330
Tax % -236% -65% 102% -1% -67% 18% -4%
16 -25 -0 59 -138 605 1,104 1,057
EPS in Rs 0.29 -0.47 -0.06 1.10 -1.42 6.24 11.37 10.88
Dividend Payout % 0% 0% 0% 0% 0% 0% 9%
Compounded Sales Growth
10 Years: %
5 Years: 21%
3 Years: 63%
TTM: 21%
Compounded Profit Growth
10 Years: %
5 Years: 115%
3 Years: 165%
TTM: 8%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 53%
1 Year: 84%
Return on Equity
10 Years: %
5 Years: 10%
3 Years: 11%
Last Year: 16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 537 537 537 537 966 970 971 972
Reserves 655 627 426 2,016 4,673 5,313 6,439 6,874
874 981 1,003 875 1,101 913 689 660
1,080 1,157 1,389 546 1,803 1,993 2,003 2,150
Total Liabilities 3,146 3,302 3,355 3,974 8,543 9,189 10,102 10,656
2,244 2,227 2,192 851 6,536 7,018 7,039 7,126
CWIP 46 38 87 28 27 151 252 254
Investments 0 0 1 2,182 1 1 1 1
856 1,036 1,075 913 1,980 2,020 2,810 3,276
Total Assets 3,146 3,302 3,355 3,974 8,543 9,189 10,102 10,656

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
156 166 89 77 118 741 1,209
-104 -124 -17 -2,641 206 -764 -1,187
-48 -48 -74 2,353 191 -294 -289
Net Cash Flow 4 -6 -2 -210 516 -317 -266

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 53 59 78 33 53 36 27
Inventory Days 20 24 26 43 34 24 30
Days Payable 184 227 292 286 274 174 212
Cash Conversion Cycle -111 -144 -188 -210 -187 -114 -155
Working Capital Days 7 -2 -136 116 -32 -13 -39
ROCE % 4% 6% 4% 7% 12% 15%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
70.46% 60.91% 60.68% 50.64% 50.64% 23.80% 23.78% 23.77% 23.76% 23.76% 23.75% 23.75%
14.05% 14.23% 16.67% 14.59% 23.34% 49.27% 50.15% 51.96% 59.89% 60.39% 60.69% 57.33%
7.95% 8.70% 15.67% 17.57% 19.42% 21.16% 20.47% 19.36% 11.90% 11.40% 11.55% 14.96%
7.54% 16.16% 6.97% 17.20% 6.61% 5.76% 5.61% 4.92% 4.45% 4.45% 3.99% 3.97%
No. of Shareholders 70,65591,9371,11,8771,20,0791,05,0001,01,6591,11,7011,04,6561,11,3741,18,6351,11,3381,27,009

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls